Literature DB >> 21304619

Antibacterial activity of extracts of three Croton species collected in Mpumalanga region in South Africa.

S C Selowa1, L J Shai, P Masoko, M P Mokgotho, S R Magano.   

Abstract

The antibacterial activities of three Croton species were compared using bioautography and the serial microdilution methods. The methanolic extracts of all the species had low activity against Escherichia coli. The highest activity was observed with Croton megalobotrys against Enterococcus faecalis with a minimal inhibitory concentration (MIC) value of 0.02 mg/ml. Croton steenkapianus extracts were the least active of the species investigated, only managing an MIC value of 0.625 mg/ml against Pseudomonas aeruginosa. Croton megalobotrys leaf powder was serially extracted using solvents of various polarities. The lowest MIC value (0.06 mg/ml) of the serially extracted fractions was observed with acetone against Pseudomonas aeruginosa. The liquid-liquid fractions of the methanol extract of Croton megalobotrys were also tested. The lowest MIC value of 0.02 mg/ml was observed with n-hexane fraction against Enterococcus faecalis. The carbon tetrachloride fraction was further fractionated using column chromatography with silica as the immobile phase. The resulting seven fractions were tested for activity following the bioassay-guided practice, and it emerged that the first three fractions had active compounds against Staphylococcus aureus when the bioautography method was used.

Entities:  

Keywords:  C. silvaticus; C. steenkapianus; Croton megalobotrys; antibacterial activity

Mesh:

Substances:

Year:  2009        PMID: 21304619      PMCID: PMC3021162          DOI: 10.4314/ajtcam.v7i2.50861

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  8 in total

1.  Traditional healers and the treatment of sexually transmitted illnesses in rural Zambia.

Authors:  P Ndubani; B Höjer
Journal:  J Ethnopharmacol       Date:  1999-10       Impact factor: 4.360

2.  Investigating the safety of plants used in South African traditional medicine: testing for genotoxicity in the micronucleus and alkaline comet assays.

Authors:  Joslyn L S Taylor; Esameldin E Elgorashi; Annemie Maes; Urbain Van Gorp; Norbert De Kimpe; Johannes Van Staden; Luc Verschaeve
Journal:  Environ Mol Mutagen       Date:  2003       Impact factor: 3.216

3.  Climate and cholera in KwaZulu-Natal, South Africa: the role of environmental factors and implications for epidemic preparedness.

Authors:  Joshua Mendelsohn; Terry Dawson
Journal:  Int J Hyg Environ Health       Date:  2007-03-23       Impact factor: 5.840

Review 4.  The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics.

Authors:  I Chopra; J Hodgson; B Metcalf; G Poste
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

5.  A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria.

Authors:  J N Eloff
Journal:  Planta Med       Date:  1998-12       Impact factor: 3.352

6.  Nature's medicinal bounty: don't throw it away.

Authors:  O Akerele
Journal:  World Health Forum       Date:  1993

7.  Screening of the topical anti-inflammatory activity of some Central American plants.

Authors:  S Sosa; M J Balick; R Arvigo; R G Esposito; C Pizza; G Altinier; Aurelia Tubaro
Journal:  J Ethnopharmacol       Date:  2002-07       Impact factor: 4.360

8.  Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: a possible alternative in the treatment of non-nosocomial infections.

Authors:  Jhon J Rojas; Veronica J Ochoa; Saul A Ocampo; John F Muñoz
Journal:  BMC Complement Altern Med       Date:  2006-02-17       Impact factor: 3.659

  8 in total
  1 in total

1.  Identification of the AntiListerial Constituents in Partially Purified Column Chromatography Fractions of Garcinia kola Seeds and Their Interactions with Standard Antibiotics.

Authors:  D Penduka; L Buwa; B Mayekiso; A K Basson; A I Okoh
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-08       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.